ClinicalTrials.gg
RecruitingNCT07872683CHO-GERIGASUpdated Oct 14, 2026

Maltodextrin Versus Sugar Water Carbohydrate Loading and Gastric Volume in Geriatric Lower Limb Orthopedic Surgery

An interventional study of Maltodextrin carbohydrate drink and Sugar water in Respiratory Aspiration, Hyperglycemia and Inflammation, sponsored by Udayana University. Recruiting at 1 site in Indonesia. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Udayana University · Not applicable, Interventional, and Supportive care

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Before surgery, patients are asked to fast so the stomach is empty and stomach contents cannot enter the lungs during anesthesia. Long fasting is uncomfortable and can raise blood sugar and stress responses in older adults. Giving a carbohydrate drink up to 2 hours before surgery is part of enhanced recovery (ERAS) programs. It is not clear whether a maltodextrin drink or sugar water leaves less fluid in the stomach of older patients.

This randomized, double-blind study enrolls patients aged 60 years and older who are having elective lower limb orthopedic surgery under spinal or epidural anesthesia at Prof. Ngoerah General Hospital in Denpasar, Indonesia. Participants are assigned by chance to drink 400 mL of either a maltodextrin carbohydrate drink or sugar water 2 hours before anesthesia. The amount of fluid in the stomach is measured with bedside ultrasound before the drink and 2 hours after it. Blood glucose is measured before the drink, 2 hours after it and 6 hours after surgery. The neutrophil-lymphocyte ratio, a blood marker of inflammatory stress, is compared before surgery and 6 hours after surgery.

The results are intended to show which drink is better suited to older surgical patients and to support safer and more comfortable fasting practice.

Read the detailed description

Design. Double-blind, parallel-group randomized controlled trial with two arms and a 1:1 allocation ratio. Participants are recruited consecutively and allocated by computer-assisted block randomization. Setting: Central Surgical Installation and inpatient wards, Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali.

Procedure. Eligible patients are selected from the elective operating list the day before surgery and give written informed consent. All patients fast from solid food for 6 hours. In the reception area, age, sex, height, weight, body mass index, last meal and fasting duration are recorded. Baseline gastric ultrasound (right lateral decubitus, curvilinear probe) and capillary blood glucose are measured, and a blood sample for neutrophil and lymphocyte counts is taken. The participant then drinks 400 mL of the assigned drink within 15 to 30 minutes, 2 hours before anesthesia. Two hours later gastric ultrasound and blood glucose are repeated by the same operator. Anesthesia is neuraxial: spinal bupivacaine heavy 0.5% 10 to 12.5 mg at L3-L4, or epidural bupivacaine up to 0.25% in 10 to 12 mL. Six hours after the end of surgery, blood glucose and a complete blood count are repeated. Surgery type, duration and blood loss are taken from the electronic medical record.

Masking. The drinks are served in identical, opaque, unbranded, closed containers labeled A or B, with the same volume, temperature and timing, and drunk through a straw. The participant, the ultrasound operator who collects the data, and the data analyst do not know the allocation. The person who prepares and hands over the drinks knows it. The drinks differ in taste and appearance, so masking of participants relies on the opaque containers.

Hypothesis. The primary hypothesis is one-sided: gastric volume 2 hours after the maltodextrin drink is lower than after sugar water. The hypotheses for blood glucose and neutrophil-lymphocyte ratio are two-sided.

Sample size. The planned sample is 62 participants (31 per arm). The calculation used blood glucose as the driving outcome (28 per group, alpha 0.05, power 80%) plus 10% allowance for dropout.

Safety. Adverse events (allergy, nausea, bloating, regurgitation, hypotension, bradycardia) are managed by the anesthesia team, recorded, and reported to the hospital patient safety committee and the ethics committee.

Analysis. Normality is tested with Kolmogorov-Smirnov and variance homogeneity with Levene. Two groups are compared with the independent t-test or Mann-Whitney test. Repeated measurements use repeated-measures ANOVA or the Friedman test. Confounders are examined by stratification and a general linear model. Software: IBM SPSS Statistics 29.

02

Conditions studied

  • Respiratory Aspiration
  • Hyperglycemia
  • Inflammation

Keywords

  • maltodextrin
  • carbohydrate loading
  • sugar water
  • gastric ultrasound
  • gastric volume
  • geriatric
  • enhanced recovery after surgery
  • neutrophil-lymphocyte ratio
  • blood glucose
  • neuraxial anesthesia
03

In context

Respiratory Aspiration

1,111 studies on the registry are indexed under Respiratory Aspiration; 219 are open to participants now.

This study's planned enrollment of 62 is above the median of 42 across 897 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Udayana University is the lead sponsor of 34 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 60 years or older with adequate cognitive function on brief cognitive screening
  • ASA physical status II or III
  • Elective lower extremity orthopedic surgery under neuraxial anesthesia

Exclusion criteria

Exclusion Criteria:

  • Emergency or urgent surgery
  • Unstable hemodynamics
  • Diagnosed gastrointestinal tract pathology
  • History of bariatric surgery
  • Dressing, wound cover or corset over the abdomen that prevents gastric ultrasound
  • Use of a proton pump inhibitor, H2 antagonist or drug affecting gastrointestinal motility (for example metoclopramide, loperamide) in the past week
  • Unable to lie in the lateral decubitus position
  • Body mass index below 19 or 35 kg/m2 and above
  • Refuses to take part after informed consent
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Maltodextrin Carbohydrate Loading

    Participants drink 400 mL (4 packs of 100 mL) of a ready-to-drink clear maltodextrin carbohydrate beverage (Maltodex, about 200 kcal) within 15 to 30 minutes, 2 hours before anesthesia, after 6 hours of fasting from solid food. The drink is served in an opaque coded container with a straw.

    Dietary Supplement: Maltodextrin carbohydrate drink

  • Active comparator
    Sugar Water Carbohydrate Loading

    Participants drink 400 mL of clear sugar water made with about 50 g of sucrose (table sugar) in drinking water (about 200 kcal) within 15 to 30 minutes, 2 hours before anesthesia, after 6 hours of fasting from solid food. The drink is served in an opaque coded container with a straw, identical to the other arm.

    Dietary Supplement: Sugar water

Interventions

  • Dietary supplementMaltodextrin carbohydrate drink

    400 mL (4 x 100 mL) of ready-to-drink clear maltodextrin beverage (Maltodex, PT Finusoprima Farma Internasional). Per 100 mL: 50 kcal, 13 g carbohydrate of which 4 g sugars, 15 mg sodium, vitamin A and zinc at 15% of daily value each. Single dose, drunk within 15 to 30 minutes, 2 hours before anesthesia. Unlike the comparator it contains added vitamin A and zinc.

    Also known as: Maltodex

  • Dietary supplementSugar water

    400 mL of clear solution prepared by the hospital nutrition installation by dissolving about 50 g of sucrose (table sugar) in drinking water to a final volume of 400 mL (about 200 kcal, no fat, no protein). Single dose, drunk within 15 to 30 minutes, 2 hours before anesthesia.

    Also known as: Sucrose solution

06

What researchers measure

Primary outcomes

  1. Gastric volume 2 hours after carbohydrate loading

    Gastric volume in mL estimated from bedside antral ultrasound in the right lateral decubitus position using the Perlas formula: volume (mL) = 27.0 + 14.6 x right-lateral antral cross-sectional area (cm2) - 1.28 x age (years). One operator, blinded to allocation.

    Time frame: 2 hours after finishing the study drink, before anesthesia

Secondary outcomes

  1. Change in blood glucose from before loading to 2 hours after loading

    Capillary blood glucose in mg/dL measured with an Accu-Chek glucometer before the drink and 2 hours after it.

    Time frame: Before the drink and 2 hours after the drink

  2. Change in neutrophil-lymphocyte ratio from before surgery to 6 hours after surgery

    Neutrophil-lymphocyte ratio calculated from the complete blood count differential (Sysmex XN-3000) of the last preoperative sample and a sample taken 6 hours after the end of surgery.

    Time frame: Last preoperative sample and 6 hours after the end of surgery

07

Study locations

1 of 1 sites recruiting
  • Prof. Dr. I.G.N.G. Ngoerah General Hospital (RSUP Prof. Dr. I.G.N.G. Ngoerah)
    Denpasar, Bali 80114, Indonesia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872683
Lead sponsor
Udayana University
Collaborators
RS Umum Pusat Sanglah, Denpasar
Responsible party
Burhan (Resident Physician, Anesthesiology and Intensive Care Therapy, Udayana University) — Principal investigator
First posted
Oct 14, 2026
Start date
Sep 27, 2026
Primary completion
Oct 31, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Oct 14, 2026

Study contacts

Burhan MD
Contact
burhan.010@student.unud.ac.id
+62 822 7622 2247
Tjahya Aryasa, Sp.An-TI, Subsp.An.O.(K)
study chair · Rumah Sakit Umum Pusat Sanglah Denpasar
I Made Prema Putra, Sp.An-TI
study chair · Rumah Sakit Umum Pusat Sanglah Denpasar
Lalu Reza Aldira Akbar, MD
principal investigator · Rumah Sakit Umum Pusat Sanglah Denpasar

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion